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ROLE OF CBLN1’S RE-1 TRANSCRIPTIONAL REGULATORY SEQUENCES 
IN GENE REPRESSION 
TRISTAN J. CRUZ 
 
ABSTRACT 
 
Background: Cbln1 is a gene whose expression is negatively correlated to seizures.  
Krishnan et al. has recently shown that seizures synergize with transcriptional co-
regulator Ube3a to repress Cbln1 expression, which ultimately manifests as ASD 
associated behavioral discrepancies. (Krishnan et al., 2017) Seizures increase the 
expression of REST and the Cbln1 gene contains an intronic RE-1 binding site previously 
shown to interact with REST. This could therefore be a point of convergence for the 
transcriptional downregulation of Cbln1. 
Objective: To determine if Cbln1’s RE-1 sequences confers gene repression to minimal 
promoter reporter system by REST and Ube3a. 
Methods: Desired RE-1 sequences from Cbln1 were subcloned into a pGL3-basic vector 
using specific restriction enzymes that flanked each DNA region. Specific 
oligonucleotide target sequences were annealed together and ligated into the plasmid 
vector before transfecting into live HEK293T cells. A minimal luciferase promoter with 
just enough sequence for the polymerase to sit was also ligated into the cassette. A 
luciferase assay was then conducted on the plated cells under exposure to separate testing 
conditions such as excess Ube3a, REST, dnREST, and various combinations of these 
  vii 
factors to determine the effect of these TFs on gene expression controlled by Cbln1’s RE-
1 site. 
Results: REST strongly, and Ube3a weakly, repressed the minimal promoter reporter 
construct when Cbln1’s RE-1 sequences were added. REST occluded the repressive 
effects produced by Ube3a indicating that their effects are not additive or synergistic. 
Conclusion: Both REST, that is increased by seizures (Krishnan et al., 2017), and Ube3a 
(more weakly) can repress gene expression when Cbln1’s RE-1 binding sequences are 
added. These repressive effects may help explain how seizures and Ube3a can decrease 
Cbln1 expression that ultimately leads to reduced sociability.  
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INTRODUCTION 
 
Central Nervous System (CNS) overview 
 
 The brain and spinal cord function in tandem as the combined center of the 
nervous system for all vertebrates and are together responsible for a myriad of life 
essential operations. These faculties include, but are not limited to: memory and learning, 
motivation and arousal, physiological homeostasis, basic perception, and motor control. 
The brain is divided into several principle sections that are further subcategorized 
according to morphogenetic development. The hindbrain (rhombencephalon) consists of 
the pons (metencephalon), medulla oblongata (myelencephelon), and the cerebellum. The 
cerebellum lies at the posterior region of the cranial fossa, beneath the occipital and 
temporal lobes. Roughly accounting for 1/10th of the brain’s overall volume, the 
cerebellum houses more than ½ of the total amount of neurons within the brain. Indirect 
afferent input to the cerebellum can originate from peripheral receptors situated 
throughout the body. The cerebral cortex also provides indirect input to the cerebellum 
via distinct neuronal networks.  
 
 
Cerebellum overview 
 The cerebellum has been principally characterized as responsible for coordination, 
not production, of motor activity. Whereas the primary motor cortex located within the 
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precentral gyrus generates neural impulses to perform motor function, the cerebellum 
functions to correct the execution of these movements and is therefore the chief 
determinant of successful reflex coordination and motor pattern mastery. The cerebellum, 
therefore, influences several components of movement such as rate, range, direction, and 
accuracy of motor control. (Ito, 2001) Countless experiments analyzing the consequences 
of cerebellar lesions yielded debilitating conditions such as ataxia, dysmetria, dysarthria, 
and hypotonia. (Strata, Scelfo, & Sacchetti, 2011) However, more recent research 
postulates potential cerebellar involvement in non-motor function including cognition 
and emotion attribution. (Hoche, Guell, Sherman, Vangel, & Schmahmann, 2016; Strata 
et al., 2011) Schmahmann et al. discovered that damage to particular regions within the 
cerebellum confer alternate deficiencies. They found that lesions to the anterior lobe 
demonstrated fine motor skill impairment, whereas injury to the posterior lobe affected 
language and executive function. (Stoodley, MacMore, Makris, Sherman, & 
Schmahmann, 2016) Schmahmann et al. coined these behavioral deficiencies as the 
cerebellar cognitive affective syndrome (CCAS), also known as the Schmahmann 
syndrome. (Schmahmann & Sherman, 1998) CCAS patients are characterized as those 
suffering from compromised executive functionality including oral articulation, abstract 
reasoning, future planning, and working memory. These patients also exhibit problems 
with visual-spatial coordination as well as changes in temperament that manifests as 
‘inappropriate behavior’ much like the symptoms associated with ASD.  (Schmahmann & 
Sherman, 1998) Ultimately, the vast Purkinje cell neuronal network associated with the 
cerebellum suggests that circuitry malfunction indirectly synapsing with higher cortical 
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areas of the brain can not only impair motor command, but may also contribute to certain 
neurological conditions such as those classified within the autistic spectrum disorders 
(ASD). (Reeber, Otis, & Sillitoe, 2013; Whitney, Kemper, Bauman, Rosene, & Blatt, 
2008)  
 
 
ASD overview 
 Autistic symptoms can manifest as underdeveloped social overtures, disjointed 
and lengthy language, intensely repetitive and isolated focus, and an overall impaired 
grasp on accepted social behavior. These characteristic features can become apparent 
physically as hindered fine motor skills and personal repetitive ticks, mentally as 
disordered social interaction, or deficits in both. (Fatemi et al., 2012) While a concrete 
determination for the cause of autism remains unclear, both environmental and genetic 
implications have been identified and are currently under further investigation in an effort 
to better understand how to approach and treat those affected with ASD’s. (Wassink, 
Brzustowicz, Bartlett, & Szatmari, 2004)  
 
 
Cbln1 in lieu of ASD 
 Cerebellin 1 (Cbln1) encodes a glycoprotein densely expressed in cerebellar 
granule cells. (Hirai et al., 2005) These granule cells secrete Cbln1 from their parallel 
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fiber (PF) axons, allowing the Cbln1 ligand to bind to the N terminal domain of 
postsynaptic glutamate receptor delta 2 (GluD 2) where their successful interaction serves 
as the crux of Purkinje cell synapse integrity. (Matsuda et al., 2010) GluD 2 not only 
mediates excitatory neurotransmission within the brain, but is also a pertinent player in 
maintaining accurate motor learning and control. (Emi et al., 2013) Jones et al. 2013 
conducted a genome wide association (GWA) studying 2,462,046 single nucleotide 
polymorphisms (SNP’s) for ASD in a cohort of 965 participants. Although they were 
unable to recognize any genome wide specific SNP association with ASD like traits 
(defined as p-value < 5.0 × 10−8), deeper investigation showed that the rs16946931 SNP 
(p = 1.78 × 10−6) is positioned beside the CBLN1 gene locus on chromosome 16q12.1. 
(Jones et al., 2013) This association provides preliminary evidence implicating Cbln1 in 
the risk of developing ASD. 
  In fact, deleting Cbln1 in mice has proven to decrease PF-Purkinje cell synapses 
by approximately 80%. This drastic loss of excitatory communication manifests in 
severely impaired motor function among the test subject mice. (Hirai et al., 2005) 
Recently Krishnan et al. has show that deletion of Cbln1 impairs sociability. (Krishnan et 
al., 2017) They selectively deleted Cbln1 in glutamatergic vesicular glutamate transporter 
type 2 (VGluT2) neurons using VGluT2-Cre mice and mice with loxP sequences flanking 
exons of Cbln1. These VGluT2Cre.Cbln1fl/fl mice displayed abated levels of Cbln1 
expression throughout the brain. Social behavior deficits were observed as these floxed 
mice displayed reduced interactions with unfamiliar females, generated far less ultrasonic 
vocalizations (USV’s), and showed an overall attenuated sociability as compared to the 
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non-floxed mice. To eliminate the potential influence of confounding behavioral 
variables, no alterations in cage exploration, olfaction, movement, or grooming were 
observed when comparing the mouse cohorts. Thus, they showed that a reduced Cbln1 
expression results in impaired sociability.  
 
 
Ube3a in lieu of ASD 
 Another gene implicated in the prognosis of autism is E3 ubiquitin ligase 3a 
(Ube3a). In a series of 100 autism cases studied, the most prevalent similarity presented 
as different aberrations to chromosome 15 with implicated candidate genes like Ube3a. 
(Schroer et al., 1998) Ube3a independently functions as both an ubiquitin ligase protein 
and a transcriptional co-regulator. (Nawaz, Lonard, Dennis, Smith, & O’Malley, 1999) 
The Ube3a gene product, also known as the E6 associated protein (E6 AP), plays an 
important role in the ubiquitin proteasome system (UPS) by imparting extensive effects 
on different protein levels within the cell. (LaSalle, Reiter, & Chamberlain, 2015) Ube3a 
also operates as a nuclear steroid hormone receptor (SHR) co-activator as it directly 
interacts with SHR target gene promoters within the transcriptional complex in a 
hormone dependent fashion. (Ramamoorthy & Nawaz, 2008; Nawaz, Lonard, Smith, et 
al., 1999) The Ube3a protein can be found profusely within the cell as it localizes to both 
nuclear and cytosolic areas. (Dindot, Antalffy, Bhattacharjee, & Beaudet, 2008)  
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Ube3a has a repressive effect on Cbln1 
 Krishnan et al. also recently showed that Ube3a downregulates Cbln1 and 
ultimately impairs sociability. ((Krishnan et al., 2017; Smith et al., 2011) An in vivo 
experiment analyzing autism-modeled mice with increased expression of Ube3a in their 
genetic makeup revealed a substantial reduction in Cbln1 mRNA levels using a 
quantitative real-time polymerase chain reaction (q-PCR) analysis.  By utilizing bacterial 
artificial chromosome (BAC) recombineering techniques, an entire mouse chromosome 7 
fragment that parallels human chromosome 15 was introduced into the FVB strain mouse 
embryos to produce transgenic mouse models containing an integrated Ube3a coding 
sequence. (Smith et al., 2011) These mice were bred to produce 1x or 2x offspring that 
were consequently FLAG-tagged for more efficient protein analysis. Ube3a single copy 
and Ube3a double copy in FLAG-tagged Ube3a mice (expressing a 2 and 3 fold increase 
in Ube3a protein production respectively) both presented a relative suppression of Cbln1 
mRNA fold change over WT in cortical samples. Even FLAG-tagged Ube3a containing 
different nuclear localization signals (Ube3aNLS) and untagged Ube3a2x repressed 
Cbln1 mRNA. Contrastingly, Ube3a maternal knockout (Ube3amKO) mice upregulated 
Cbln1 mRNA.  
 A three chambered social approach task measuring sociability in these transgenic 
mice tested whether the mice were more likely to associate with a novel mouse or novel 
inanimate object when both were presented in separate chambers. Sociability was 
essentially defined as the extent of time spent with the novel mouse over novel object, 
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while direct sociability was represented by time spent sniffing. (Yang, Silverman, & 
Crawley, 2011) Ube3aNLS and Ube3a2x mice both FLAG tagged exhibited impaired 
sociability, while Ube3a1x mice and Ube3amKO mice displayed no such repression. 
Ube3a, therefore, may promote ASD like mannerisms in terms of curbed sociability via a 
mechanistic downregulation of Cbln1. (Krishnan et al., 2017) 
 
 
Seizures also have a repressive effect on Cbln1 
 Decreased expression of Cbln1 mRNA is also induced by increasing extracellular 
K+ concentrations to depolarize fully developed cerebellar granule cells. Elevated K+ 
excites these neurons, causing an activity dependent effect that lowers Cbln1 gene 
expression. Status epilepticus (SE) mimics these effects of chronically elevated activity to 
repress Cbln1 mRNA production. (Iijima, Emi, & Yuzaki, 2009)  
  Confirming that seizures repress Cbln1 and showing that this decrease of Cbln1 
expression correlates to decreased sociability was studied by subjecting a batch of WT 
mice to 10 sequential daily injections of pentylenetetrazole (PTZ) in safe dosages. PTZ is 
a gamma-aminobutyric acid (GABA) antagonist, and thus promotes excitatory 
stimulation. These recurrent seizures escalated in intensity, culminating in a decrease of 
Cbln1 mRNA expressive measurements throughout the brain after an elapsed time of 24 
hours. This downregulation ultimately manifested in reduced USV’s and sociability over 
the next month. (Krishnan et al., 2017) 
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Ube3a synergizes with seizures to repress Cbln1 
 Krishnan et al. also found that Ube3a synergizes with epileptic seizures to 
downregulate Cbln1 mRNA. (Krishnan et al., 2017) When Ube3amKO and WT littermate 
mice were similarly treated with 10 successive PTZ injections, knockout mice 
demonstrated no associative sociability impairments that have previously been evidenced 
with seizure induction. Whereas moderate applications of PTZ injections at 30mg/kg 
doses 5 times on a 48 hour administration synergized in the Ube3a1x mice to produce 
sociability impairments. Sub-threshold administration of the GABA antagonist rendered 
quantitative measurements of sociability deficits, while WT mice injected with the same 
convulsant remained unfettered.  This relative convergence between Ube3a and seizure 
induced Cbln1 repression offers insight on a synergistic relationship between the two 
variables and their cohesive effect on hindering social behavior.  
 
 
Seizures also increase REST levels 
 Seizures have also been shown to increase hippocampal (Garriga-Canut et al., 
2006)and ventral tegmental area (VTA) (Krishnan et al., 2017) concentrations of the RE-
1 silencing transcription factor (REST) also known as neuron restrictive silencer factor 
(NRSF). Moreover, greater intensity and protracted seizure symptoms develop an 
epileptic condition that also more strongly induces increased REST levels. (Calderone et 
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al., 2003; Kaneko, Hwang, Gertner, Pontarelli, & Zukin, 2014; Noh et al., 2012) Much 
like the systemic delivery of PTZ to induce seizure like symptoms within an in vivo rat 
model, a separate glutamate receptor antagonist known as kainic acid (KA) was steadily 
administered to mice to produce a similar epileptic outcome. Consequently, hippocampal 
measurements of REST mRNA and ensuing REST protein translational expression 
presented at elevated levels. (McClelland et al., 2014) To confirm a direct correlation 
between seizures and increased REST expression and therefore dispel the possibility of in 
vivo confounding mediator to the relationship, an earlier in vitro application was 
conducted wherein hippocampal brain slices were treated with KA which yielded the 
same upregulatory REST outcome. (Richichi et al., 2008) 
 
 
REST overview and transcriptional repression via RE-1 sequence binding 
 REST contains 3 functional domains that include separate repressor sites at the 
amino and carboxy ends respectively, and a DNA binding domain with 8 zinc finger 
motifs. The DNA binding domain binds to the RE-1 motif also known as neuron 
restrictive silencer element (NRSE). (Bruce et al., 2004) REST epigenetically regulates 
neuronal genes containing this conserved 21 base pair (bp) RE-1 region by binding to it 
and repressing transcription to ultimately influence the genetic framework for overall 
neuronal function. (Chong et al., 1995; Schoenherr & Anderson, 1995) Microarray 
analysis has previously identified 371 genes from a total of 12,996 (or 2.8%) in the rat 
hippocampus that contain RE-1 sequences. Separate assays determined that of the 470 
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genes repressed as a result of epileptic seizure administration, 39 (or 8.3%) also contain 
RE-1 binding sites for REST. The significant difference between minimal amounts of 
RE-1 sites in the conglomerate gene population (2.8%) vs. the much greater amounts of 
these sites in downregulated genes (8.3%) suggests the important role of RE-1 binding 
sites in seizure induced gene repression by REST.  
 A study to determine the explicit correlation of REST mediated gene repression 
via RE-1 binding interaction was conducted by creating false oligonucleotide RE-1 
inhibitory (RE-1) sequences in an effort to prevent REST recruitment and measure the 
consequent changes in gene expression. In vitro REI sequence containing 
oligodoexynucleotides (ODNs) were introduced into in vivo rat brains to function as a 
competitive inhibitor of REST binding. These ODNs blocked REST association and 
ultimately negating its downregulatory function. 72% of the RE-1 motifs containing 
seizure-REST repressed genes were no longer markedly inhibited when ODNs were 
introduced. These results directly contrasted the higher rates of repression expected in the 
canonical REST control condition. (McClelland et al., 2014) REST, therefore, executes 
its repressive behavior by linking to DNA containing RE-1 binding sites and neutralizing 
gene transcription and subsequent protein translation. 
 
 
 
 
 
 11 
SPECIFIC AIM 
 
Test if Cbln1’s RE-1 sequences confer gene repression by REST 
 A prospective gene of interest for seizure induced REST repression is the 
aforementioned Cbln1 gene. Figure 2 illustrates how intron 2 of Cbln1 includes a 
consensus RE-1 sequence. (Kent et al., 2002) Figure 1 shows how the Cbln1 gene also 
includes a wide array of TF and cofactor binding sites such as HDAC2 and SIN3a that 
may interact with the RE-1 sequence to form transcriptional regulatory complexes that 
ultimately modulate gene expression. The presence of an RE-1 sequence between exons 2 
and 3 of the Cbln1 gene suggests a potential binding site for REST interplay.  This may 
also serve as a site of convergence for Ube3a coregulation either in a synergistic, or 
singular mechanism at the Cbln1 RE-1 site. Ube3a also, however, may impact Cbln1 
expression through an alternate binding site outside the RE-1 motif. This study aimed to 
determine whether the RE-1 binding sequences of the Cbln1 gene could confer repression 
of a minimal promoter by REST and whether Ube3a can also act on gene expression 
through those same sequences. 
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Figure 1: UCSC genome browser Cbln1 with associated TFs. Blast-like alignment 
took (BLAT) whole genome index analysis of the Cbln1 gene highlighting REST/RE-
1 binding site and a select cohort of the other TFs that interact with Cbln1 at their 
specific recruitment sites via ChIP-seq. Adapted from (“Human chr16:49311829-
49315742 - UCSC Genome Browser v346,” n.d.) 
 
 
Figure 2: Simplified depiction of Cbln1 gene. Representation of the Cbln1 gene 
emphasizing the location of the SP-1, RE-1, and exon sequences. 
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METHODS (research-based) 
Target Guide Sequence Cloning Protocol  
 
 
Figure 3: Set min-P 3xRE-1 cassette. Construct design identifying the precise 
enzymatic cut sites utilized for the insertion of desired RE-1 sequences and min-P 
later tested in luciferase assays.  
 
Subcloning by restriction enzyme digest requires a recipient vector, the pGL3-
basic vector illustrated in Figure 4, which contains a multiple cloning region that has the 
same restriction cut sites as those flanking the desired insert. Figure 5 displays the min-P 
3xRE-1 cassette design displaying the various specific and non-repetitive cut sites 
flanking each DNA plasmid insert. The luciferase minimal promoter (min-P) was cloned 
using the HindIII enzyme cut site. Cutting between the XmaI and BglII restriction sites 
cloned the first RE-1 sequence out, while the remaining 2 RE-1 motifs were cloned by 
cutting between KpnI and XmaI. The vectors (singular min-P and min-P with 3xRE-1 
sequence) were digested with these specific enzymes and also treated with a 10X digest 
buffer and DL-Dithiothreitol (DTT) to stabilize the enzymes containing free sulfyhydryl 
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groups. To ensure optimal DNA conservation and cutting, the digests ran for 30 minutes 
at 37°C before running them in wide comb wells on a 0.8% agarose gel.  
 
Figure 4: pGL3-Basic Vector. The pGL3-Basic vector is deficient of any eukaryotic 
promoter and enhancer sequences to ensure optimal efficiency of DNA plasmid 
ligation. Successful luciferase expression of cells containing the transfected gene 
sequences is contingent on accurate infusion of desired plasmids promoter 
sequences upstream the luciferase+ (luc+) gene. The pGL3 vector also includes 
embedded Ampicillin resistance (Ampr), origin of replication (ori) sites, and a 
multiple cloning region that includes specific cut sites for the individual enzymes 
used to clone target sequences (HindIII, BglII, and KpnI) that were previously 
mentioned. The direction of the arrows reflect in luc+ and Ampr reflect 
transcriptional direction. Adapted from (“pGL3 Luciferase Reporter Vectors 
Technical Manual TM033 - pGL3 Luciferase Reporter Vectors Protocol.ashx,” n.d.) 
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The cut DNA plasmid vectors were then extracted from the gel by using a razor 
blade and weighed in separate 1.5 microcentrifuge tubes. Once the individual plasmid 
weights were determined, 3x specific gel volume of a buffer containing a pH indicator 
was added to the associated tubes before submerging them into a 50°C water bath for 10 
minutes to melt the gels. The tubes were intermittently vortexed to assist homogenization. 
To ensure a pH indication of yellow, a small amount (about 10µl) of sodium acetate 
(NaAc) at a pH of 5.0 was added to the mixes. Gel volumes of 100% isopropanol were 
added to each tube before transferring the mixtures to separate filtered spin columns.  The 
columns were then applied to a vacuum until the contents of each tube completely ran 
through the different filters. The filters were then washed through with another buffer 
before placing the spin columns in collection tubes and centrifuging them at 13,000 
revolutions per minute (rpm) for 1 minute to remove residual buffer. The DNA 
containing filtered spin columns were then placed in fresh 1.5 microcentrifuge tubes 
before treating them each with 50µl of elution buffer (EB/10mM Tris-Cl at pH 8.5). To 
elute the DNA, the tubes were centrifuged for another minute under the same speed 
parameters as previously mentioned, allowing the fresh 1.5 microcentrifuge tubes to 
collect the eluted cut DNA plasmids. 
 In order to clone the specific target sequences (for min-P, RE-1, and 2xhRE-1) 
into the desired pGL3 vectors, selected oligonucleotides were synthesized and annealed 
together with distinct overhangs in the thermocycler under specific parameters (37°C for 
the first 30 minutes. 95°C for 5 minutes then gradual decrease to 25°C by 5°C every 
minute). Each of these reactions were conducted at room temperature and allowed to 
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occur over a 5-minute reaction period. These annealed oligonucleotides, shown in Table 
1, were then diluted in in distilled water (ddH2O) at a 1:200 ratio to prepare for ligation 
into the open pGL3 vectors. Because the luciferase min-P was cut with only one enzyme, 
it was also treated with calf alkaline phosphatase (CIP) to prevent plasmid reformation 
into its circular shape. After applying CIP to the plasmid, it was then ready for ligation 
into the pGL3-basic vectors. The diluted oligonucleotides were then ligated into the 
recipient vectors with a quick acting ligase and incubated at room temperature for 10 
minutes.  
 
Transfection 
 The plasmid DNA were then transfected into eukaryotic human embryonic kidney 
cells (HEK293T cells). The HEK293T cells contain the SV40 large T antigen for 
optimization of lentiviral vector production and ultimately promote maximum plasmid 
transfection proficiency. According to the Invitrogen Lipofectamine™ Reagent Protocol, 
a 4-day process was initiated by plating the cells onto a 96 well plate to prepare for a 70-
90% confluence before transfection (desired confluence of 1-4 x 104 cells per well). 
Lipofectamine™ reagent was then diluted into a separate tube containing DMEM and 
thoroughly mixed using a vortex under specific concentrations shown in Table 2.  
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Table 1: Oligonucleotide cloning sequences targeted for annealing and restrictive 
enzymatic cuts. Table 1 lists the specific complementary oligonucleotide sequences 
needed to clone desired targets (min-P, RE-1, 2xhRE-1) into a pGL3 basic vector 
construct. Top and bottom represent corresponding halves to be phosphorylated 
and annealed before vector ligation. Blue = palindromic fold loop. Red = ½ target 
sequence to be annealed. Black = nucleotide overhang. 
 
Cloning Target Oligonucleotide Cloning Sequence 
Min-P Top AGCTTAGACACTAGAGGGTATATAATGGAAGCTCGACTT
CC 
Min-P Bottom AGCTGGAAGTCGAGCTTCCATTATATACCCTCTAGTGTCT
A 
RE-1 Top CCGGGTTCAGCACCACGGACGGGGCA 
RE-1 Bottom GATCTGCCCCGTCCGTGGTGCTGAAC 
2xhRE-1 Top CTTCAGCACCACGGACGGGGCCTCGAGTTCAGCACCACG
GACGGGGCC 
 
2xhRE-1 
Bottom 
CCGGGGCCCCGTCCGTGGTGCTGAACTCGAGGCCCCGTC
CGTGGTGCTGAAGGTAC 
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Table 2. Transfection reagent concentrations. Table 2 lists the calculated 
concentrations of DMEM, P3000™, and lipofectamine reagent™ needed to prepare 
separate master mixes for DNA plasmid transfection. The 10l of DMEM was split 
between two separate tubes at 5l each so that one tube was mixed with 
lipofectamine™, while the other was mixed with the appropriate blend of DNA 
plasmids and P3000™ before ultimately combining the two separate blends 
together. 
 
Reactants Concentrations 
DMEM 10l (5l between 2 tubes) 
P3000™ 0.2l 
Lipofectamine Reagent™ 0.25l 
 
 Table 3 reflects the separate DNA plasmid master mixes prepared according to 
the desired condition requirements. The DNA plasmids were then treated with P3000™ 
reagent at 2l/g of DNA and added to the other tube containing DMEM medium. These 
separate tubes were then mixed together and incubated at room temperature for 20 
minutes before adding the DNA-lipid complex to the cells in each plate well. Final 
incubation of the cells lasted for another 3 days at 37°C, with routine daily analysis of the 
transfected product. 
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Table 3. Transfection DNA plasmid concentrations. Table 3 describes the necessary 
diluted DNA plasmid concentrations to be added to DMEM and P3000™ before 
lipofectamine transfection. Each tested condition (control, Ube3a, REST, dnREST, 
Ube3a + REST, and Ube3a + dnREST), received 50ng of the min-P luciferase 
plasmid, and then an appropriate assortment of control or test condition 
plasmids.For example, to measure only Ube3a’s effect on Cbln1 expression through 
RE-1 sequences, 50ng of min-P luciferase, 25ng of Ube3a, and 25ng of plasmid 
cDNA (pcDNA) control was mixed amd added to the DMEM/p3000™ tube. The 
total DNA plasmid concentration was calibrated to equal 100ng since the cells to be 
transfected were plated in a 96-well plate. 
 
Plasmid vs. 
Condition 
 
Control Ube3a REST dnREST Ube3a + 
REST 
Ube3a + 
dnREST 
min-P 
Luciferase 
 
50ng 50ng 50ng 50ng 50ng 50ng 
Ube3a 
 
0ng 25ng 0ng 0ng 25ng 25ng 
mCherry 
 
25ng 0ng 25ng 25ng 0ng 0ng 
REST 
 
0ng 0ng 25ng 0ng 25ng 0ng 
dnREST 
 
0ng 0ng 0ng 25ng 0ng 25ng 
pcDNA 
 
25ng 25ng 0ng 0ng 0ng 0ng 
Total DNA 
(ng) 
 
100ng 100ng 100ng 100ng 100ng 100ng 
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Luciferase Assay 
 The luciferase assay allows for a high-throughput evaluation of promoter 
transfection efficiency by infusing a monomeric firefly and Renilla luciferase reporter 
gene containing plasmid into the target promoter and analyzing its fluorescence after cell 
lysis via a special luciferase detergent reagent buffer. The luciferase gene encodes the 
luciferase enzyme that oxidizes D-luciferin when exposed to oxygen (O2), magnesium 
(Mg2+), or adenosine triphosphate (ATP) to yield a measureable luminescence output that 
directly correlates to mRNA levels. (Smale, 2010) 
 The luciferase assay conducted was modeled after the Dual Glo® Assay System 
protocol. The 3xRE-1 and minP transfected PGL3 vector cells of interest were grown 
separately on a 96-well plate and incubated at room temperature (20-25°C). Diluted 
Dual-Glo® Luciferase Reagent was added to each well at the appropriate concentration 
and mixed to promote thorough cell lysis. Since the half-life of the luciferase signals is 
approximately 2 hours, and because it takes roughly 10 minutes for the luciferase 
enzymes to equilibrate and completely lyse the cells, the treated culture media were 
incubated at room temperature for about 15 minutes. After the necessary time has 
elapsed, firefly luciferase luminescence was measured in relative light units (RLU) using 
a luminometer. Appropriate volumes of Dual-Glo® Stop and Dual-Glo® Luciferase 
Reagent were then added to each well and incubated at room temperature. After 15 
minutes, Renilla luminescence was measured in the same order as firefly luminescence. 
All reagents were optimized for use at room temperature.  
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Figure 5: min-P, RE-1, and 3xRE-1 luciferase constructs. Simplified luciferase 
construct design portraying the separate conditions measured in the luciferase assay 
(luciferase min-P alone vs. 3xRE-1 sequences from Cbln1 upstream from the 
luciferase promoter). 
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RESULTS 
 
 
Figure 6. Ube3a and REST regulation of RE-1 sequences. Luciferase luminescence 
measured in RLU for different conditions to determine the individual Ube3a and 
REST regulatory influences on RE-1 sites present within the Cbln1 gene. 
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 Overexpressed Ube3a displayed expected null effects on the minimal promoter 
construct absent the additional Cbln1 specific RE-1 sequences. In the 3xRE-1 condition, 
however, excess Ube3a showed a subtle repressive effect on luciferase relative 
luminescence. Increased in vitro application of REST to the 3xRE-1 motif exhibited a 
vast decrease in Cbln1 to roughly half of the expected control level. Exposure of both 
3xRE-1 and solo minimal promoter constructs to profuse concentrations of dominant 
negative REST (dnREST) blocked REST repression of Cbln1 expression. Instead of the 
of displaying projected Cbln1 levels that equaling the control values, both test conditions 
instead presented minor increases in expression that surpassed baseline control. In 
analyzing the effects of concurrent exposure of Ube3a and dnREST to both sets of 
constructs, there is no change in the lone minimal promoter output of Cbln1 expression 
while the 3xRE-1 sequences show a minor decrease. In fact, the results nearly exactly 
mirror the outcome of exposure to excess Ube3a alone. When the solitary minimal 
promoter condition was treated with concomitant Ube3a and REST, there was no 
regulation of Cbln1 as expected. In the case of the 3xRE-1 condition, however, Cbln1 
expression was considerably lowered. 
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DISCUSSION 
 
Cbln1’s RE-1 sequences confer weak repression by Ube3a 
 Ube3a marginally repressed luciferase activity in the 3xRE-1 sequence construct 
suggesting Ube3a might repress gene expression in part by acting on those sequences. 
Previous studies of increased Ube3a copy number variation in Ube3a2x mice have shown 
a gene dose dependent negative correlation between Ube3a and Cbln1 mRNA levels in 
cortical nuclear samples. (Krishnan et al., 2017) Mice with increased genomic copies of 
Ube3a mimicked traits associated with ASD such as handicapped social interaction, 
stereotypically monotonous focus and behavioral grooming, and impaired vocalizations. 
Most evident was the repression of glutamatergic excitatory synaptic transmission. 
(Smith et al., 2011) 
  
 
REST and dnREST effect on gene expression through Cbln1’s RE-1 sequences  
 The 3xRE-1 minimal promoter treated with excess REST exhibited an expected 
outcome of strong repression of luciferase activity to half of the control value. 
Additionally, applying surplus dnREST (dominant negative REST) to both test 
conditions with and without 3xRE-1 sequences from Cbln1 failed to show a strong effect 
on luciferase luminescence suggesting minimal baseline endogenous REST effects. The 
mutated dominant negative REST gene would inhibit endogenous REST and therefore 
provide a means of antagonizing native REST function. (Sheppard, 1994) Interestingly, 
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the blocking effect of dnREST on both sets of constructs shows a modest non-significant 
increase of luciferase activity above baseline control levels. This slight elevation can 
potentially be attributed to inhibition of low levels of endogenous REST concentrations 
not accounted for in the aforementioned exogenous overexpressed applications. To 
determine if endogenous REST does play a role in regulation, construction and infection 
of a dnREST AAV (Adeno-associated virus) in vivo into mice and subsequent analysis of 
Cbln1 levels would be a future step.  Ultimately, these findings support the hypothesis 
that seizure induced increases of REST might lead to RE-1 interactions that 
epigenetically act to downregulate Cbln1 gene expression and thereby impair sociability. 
(Krishnan et al., 2017) 
 
 
Concurrent Ube3a and dnREST effects on Cbln1’s RE-1 sequence-mediated gene 
regulation 
 Ube3a produced a small but significant repression of the reporter carrying 
Cbln1’s RE-1 sequences. Exposure of simultaneous Ube3a and dnREST produced similar 
effects as Ube3a alone. This suggests Ube3a repression of luciferase expression is 
unaffected by the presence of dnREST. Ube3a may therefore function independently of 
REST when influencing reporter expression through the RE-1 sequences.  
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Concurrent Ube3a and REST effects on Cbln1’s RE-1 sequence-mediated gene 
regulation 
 When the 3xRE-1 luciferase reporter was treated with simultaneously with Ube3a 
and REST overexpression, luciferase repression was no greater than with REST alone. 
These results further suggest a lack of synergy between Ube3a and REST via Cbln1’s 
RE-1 sequences. Both treatments of Ube3a and REST involve in vitro overexpression of 
the distinct proteins at non-physiological levels. The drastic repression illustrated by 
excess REST in both individual REST and simultaneous Ube3a-REST treatment may 
therefore represent a floor effect of luciferase repression wherein no further suppression 
can be physiologically produced. An in vivo experiment blocking REST and/or Ube3a 
might permit a more physiological approach.  
 
 
REST effect w/o canonical RE-1 sites 
 A peculiar effect on luciferase repression was observed with excess REST 
treatment on the minimal promoter without Cbln1 3xRE-1 sites. REST, therefore, seems 
to have widespread functional capabilities as an upregulator of gene expression when RE-
1 sequences are absent, while downregulating gene expression when RE-1 sequences are 
present. REST has been shown to activate expression of other genes including CHRNB2, 
CRH, PAX4, and OPRM1 in alternate cell conditions. (Abramovitz et al., 2008; Armisén, 
Fuentes, Olguín, Cabrejos, & Kukuljan, 2002; Bessis, Champtiaux, Chatelin, & 
Changeux, 1997; Kemp, Lin, & Habener, 2003; Kim et al., 2008; Seth & Majzoub, 2001)  
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REST mRNA can sometimes exist as an alternatively spliced isoform that in turn confers 
unconventional REST functionalities. (Palm, Belluardo, Metsis, & Timmusk, 1998)  A 
well-studied isoform is a truncated protein pseudo-version of REST known as REST4 
that ironically inactivates normal repressive REST function by averting corepressor TF 
recruitment. (Palm et al., 1999) It has also been postulated that REST4 may assume a 
more concrete role in transcriptional regulation by directly activating REST target genes. 
(Spencer et al., 2006)  
 Another finding to consider when trying to explain the increased luciferase 
expression when treated with increased REST with the RE-1 sequences missing is the 
presence of small RNAs (sRNA) within the REST binding domain of other genes within 
the cells being used for these studies that might indirectly regulate other genes that can 
secondarily induce alternative regulatory outcomes. Double stranded sRNAs have 
previously been reported as REST target gene activators. (Kuwabara, Hsieh, Nakashima, 
Taira, & Gage, 2004) In a study analyzing the correlation between sRNA presence and 
REST readouts, a significant percentage of the REST sequences containing sRNAs 
produced substantially higher levels of target gene expression than REST sites without 
sRNAs. (Rockowitz et al., 2014)  
 An interesting factor that perhaps also influences the unexpected REST driven 
upregulation of luciferase expression without any RE-1 sites may lie in uncommon 
chromatin variations within REST binding motifs. Chromatin immunoprecipitation 
sequencing (ChIP-seq) analysis on immunologically pertinent human CD4+ primary T 
cells was cross-examined with REST ChIP-seq statistics from month long matured 
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human neurons via the encyclopedia of DNA elements (ENDODE) project. (ENCODE 
Project Consortium, 2011) REST binding domains were standardized against ChIP-seq 
peaks across the varied cell types and showed the presence of both canonical and non-
canonical RE-1 binding motifs as shown in Figure 10. The unorthodox RE-1 sequence 
presented as a distinct 1-10 nucleotide interpolation dividing the canonical 21 bp motif 
into two separate parts. (D. S. Johnson, Mortazavi, Myers, & Wold, 2007; R. Johnson et 
al., 2008) The ChIP-seq cross-reference identified that many of the REST ChIP peaks 
contained only a singular side of the split canonical binding site. The analysis displayed 
that while a large percentage of the human CD4+ T cells carried the canonical RE-1 
binding sequence, the same was not true for the differentiated human neuronal cells as 
only a very small portion contained the common motif. A different GGAAA/TA 
sequence, instead, was more frequented among the ChIP-seq REST peak crosses.  
 In a separate study analyzing the different RE-1 binding site sequences, active 
histone conformations H3K4me3, H3K4me1, and H3K36me3 displayed a considerable 
overlap with the REST peaks. These findings suggest that alternative combinations of 
different REST cofactor colocalizations may serve as the primary culprit behind the 
distinctive upregulatory effect of REST at non-canonical RE-1 binding sequences. 
(Rockowitz et al., 2014) Despite these evidences, little is still known about the purpose 
behind the enhancing influence of REST on gene expression so further study 
investigating this conundrum would prove vital to understanding the diverse functional 
array of REST. 
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Figure 7: Canonical and non-canonical nucleotide substitutions of REST-RE-1 21 
bp binding site motif. Figure # is a diagrammatic representation of the 21 bp RE-1 
binding site. It compares the human motif to 3 separate sequences found in mice, 
underscoring the different nucleotide replacements between and among the varied 
species. The size scale of the particular nucleotide represents the frequency with 
which that exact nucleotide appears in that precise location between compared 
motifs. For example, CAG occupying positions 3-5 are standard throughout the 
contrary motifs and are therefore drawn to maximum scale. 
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CONCLUSION 
 
 Based on the supporting literature and the luciferase assay, one can conclude that 
REST interacts with Cbln1’s RE-1 binding sequences to repress gene expression. These 
findings suggest that REST might also repress Cbln1 gene expression through RE-1 
sequences in the context of the intact Cbln1 gene. This experiment, however, tested 
HEK293T cells with an excess amount of these transcriptional regulators, yielding either 
absolute maximum or minimum expression values. This in vitro approach demonstrates 
the overall effect of REST on Cbln1’s RE-1 sequence, but it fails to delineate an accurate 
representation of in vivo regulation of Cbln1 expression.  
 
 
Next steps  
 Future steps to deducing how Ube3a and REST function on a molecular level 
should therefore include a separate in vivo design wherein the endogenous expression 
levels of REST and Ube3a are manipulated such as using shRNA or lox-Cre conditional 
deletions of the native genes.  
 Condon et al. previously utilized shRNA Ube3a knockdown cell lines to 
determine Ube3a’s critical role in pH-dependent functions of the Golgi Apparatus (GA). 
They used shRNA sequence #12894 from Sigma’s Mission shRNA target kit against 
mouse Ube3a in a pLKO puromycin vector (sense sequence: ccc aat gat gta tga tct aaa). 
They then transfected this puromycin vector containing shRNA sequence into 239T cells. 
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After a couple of days, they treated these cells with 1mg/ml of puromycin to isolate the 
shRNA against Ube3a expressing clonal copy stable cell lines that knocked down Ube3a. 
(Condon, Ho, Robinson, Hanus, & Ehlers, 2013) The same shRNA hairpin sequence 
targeting Ube3a could then be subcloned into an AAV viral transfer vector. This transfer 
vector would then be co-transfected into HEK293T cells to generate AAV particles 
(Figure 8). 
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Figure 8: AAV Plasmid System. Mock construct of shRNA targeted Ube3a 
transfection into AAV vector and contransfection into stable HEK 293T cell lines. 
Adapted from (“Addgene: Adeno-associated virus (AAV) Guide,” n.d.) 
 
 The AAV virus targeting Ube3a knockdown could then be stereotaxically injected 
into the VTA of mice as referenced by the Anderson lab. (Krishnan et al., 2017) 
Vibratome slices of the VTA with a co-injected green fluorescent protein (GFP) reporter 
would provide a visual means to confirm a successful injection of knocked down Ube3a. 
One could then perform a punch biopsy of the VTA to prepare for RNA extraction. This 
RNA could then be reverse transcribed into complimentary DNA (cDNA) to allow for 
qPCR analysis of Cbln1 mRNA fold change. Similar methodology could be applied to a 
separate cohort of mice with shRNA targeting REST. 
 Such studies in mouse brain would allow use to evaluate the effects of seizure 
regimens while also evaluating their effects on endogenous Ube3a, REST, and Cbln1 
expression levels. qPCR analysis of Cbln1 mRNA fold change in brain regions known to 
strongly express REST might give a more reliable depiction of in vivo REST regulation 
when compared to WT Cbln1 mRNA levels. Additional studies on the effects of these 
interventions on sociability would also enable one to evaluate how REST might 
epigenetically affect gene expression to ultimately alter behavioral mannerisms. 
 It may also be too simplistic to assume that Ube3a and REST act alone in their 
coregulatory functions. As is evident in Figure 1, several other TFs bind to the Cbln1 RE-
1 sequences. It is possible that these other regulators may influence the individual or 
combined effects of Ube3a and REST respectively in either a synergistic or antagonistic 
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manner. Perhaps many TFs are recruited to form a protein complex that functions to 
regulate transcription in a combinatory fashion. Future research into the different roles of 
these other TFs like SIN3a, HDAC2, and BACHI could therefore reveal valuable key 
mechanistic insights into how Cbln1 gene expression is regulated. These interactions can 
also be tested in the same way, and can even be selectively silenced using short hairpin 
RNA (shRNA).  
 
 
Behavioral Implications 
 Although there is an extensive gamut of factors (both genetic and environmental) 
involved in the diagnosis and prognosis of ASD (“The Emerging Picture of Autism 
Spectrum Disorder,” 2015), large strides have been taken amongst many researchers to 
chip away at the ASD puzzle so as to better understand how to treat and ultimately 
prevent its onset. The Anderson Lab recently discovered (Krishnan et al., 2017) that the  
Cbln1 gene is a point of intersection between molecular mechanism and the physical and 
social manifestations of ASD. A more in depth comprehension of the different aspects 
that lead to its repression, and in turn, to ASD like symptoms will prove vital as primary 
targets for prevention and treatment. For example, a theoretical pharmaceutical could be 
developed targeted at the RE-1 sequence binder that might competitively inhibit REST 
association post seizure and the effects on Cbln1 expression. Another potential outlet 
could be an inhibitor that binds REST directly as an antagonist so that its potential 
downregulatory effects at the RE-1 and at other binding sequences will be nullified. 
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These simple ideas are just rudimentary introductions to potential advances for a much 
more personalized and sophisticated approach in addressing the role of seizure, REST, 
and RE-1 sequences on Cbln1 expression and their ultimate impact on mental and 
physical health.  
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